NYSE · IH
iHuman financials
$1.14−0.87%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 | Q4 '20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — |
| Diluted shares | 267.6M | 271.2M | 273.8M | 270.2M | 266.6M | 226.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $164.5M | $153.9M | $171.5M | $1.05B | $855.4M | $861.7M |
| Short-term investments | $0.00 | $6.2M | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $195.6M | $194.5M | $204.9M | $1.33B | $1.10B | $1.05B |
| Total liabilities | $53.3M | $62.9M | $69.6M | $563.9M | $492.5M | $404.3M |
| Shareholders' equity | $142.2M | $131.6M | $135.3M | $769.5M | $608.4M | $642.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology